Please login to the form below
Targovax appoints chief financial officer
Dr Erik Digman Wiklund succeeds Oystein Soug
Targovax has appointed Dr Erik Digman Wiklund as its new chief financial officer from April this year, succeeding Oystein Soug who became the firm's chief executive officer in November 2016.
Dr Wiklund joins the Oslo, Norway-based immuno-oncology specialist from Aker Biomarine Antarctic, where he served as director of product innovation.
He also brings experience from cancer biotech Algeta ASA, and management consulting expertise from McKinsey & Company's pharma and healthcare practice.
Soug said: “We are delighted to announce the appointment of Erik as our new chief financial officer.
“He has an impressive track record in commercial and operational roles in the biotechnology industry, combined with a strong scientific background.
“Erik's breadth of expertise will be key as we approach a number of important milestones in 2017 and 2018 within our innovative clinical pipeline, designed to help patients' own immune system to fight cancer.”
Featured jobs
- Senior Account Director or Business Unit Director, Healthcare Ad...
-
C£60, 000 – £70, 000 benefits
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Medical Writer, Healthcare Advertising
-
£35 - £45, 000 benefits
-
Senior Account Manager
-
Competitive salary commensurate with experience
- Medical Writer - Medical Communications
-
£30, 000 - £40, 000 according to skills and experience plus benefits
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Multi-Channel Account Managers - Road / Homebased – Full or Part...
-
Competitive salary
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Science Writer – Healthcare Advertising
-
Salary TBC
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
Subscribe to our email news alerts
- Genetic testing: nothing to write home about?
- Advancing women in healthcare
- Patient engagement hygiene factors
- Another R&D flop for Incyte, but Jakafi keeps delivering
- Heron boosted by new data for ‘breakthrough’ pain drug
- Daily Brief: Airbus relocation woes, inflated taxes will pay for NHS boost, NICE OK's Sanofi's Dupixent and more
PMHub
FCB Halesway
A Eureka moment! A converted dairy in the Hampshire countryside back in 1993 saw the inception of Halesway as a...
Latest intelligence
- Advancing women in healthcare
- Fostering the next generation of leaders...
- The Challenges Of UX In Healthcare: Technology To Change Lives
- Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
- It’s all about patient outcomes… right?
- Lessons from history: a design thinking perspective...
Quick links
Infographics
